Assembly Biosciences Inc (NASDAQ: ASMB) has reported E.P.S. of $-1.66 for its first fiscal quarter (ending March 31) versus $-0.37 for the same period a year ago. For the latest four quarters through March 31, E.P.S. were $-11.26 compared to $-1.82 a year ago.
Recent Price Action
On 5/8/24, Assembly Biosciences Inc (NASDAQ: ASMB) stock increased 1.8%, closing at $12.85. However, this advance was accompanied by below average trading volume at 77% of normal. Relative to the market the stock has been strong over the last nine months and has risen 3.0% during the last week.
Current PriceTarget Research Rating
ASMB’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Assembly Biosciences has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Assembly Biosciences has a very low Appreciation Score of 6 but a slightly positive Power Rating of 69, and the Negative Value Trend Rating results.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment